Venus Dermatology & Internal Medicine P A is categorized under Health Services in Odessa, FL and active since 2009.
Venus Dermatology & Internal Medicine P A was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 621999 by the NAICS.
If you are seeking more information, feel free to contact Gil Y Cortes at the company’s single location by writing to 9923 Menander Wood Court, Odessa, Florida FL 33556 or by phoning (813) 920-4036. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Venus Dermatology & Internal Medicine P A |
Contact Person: | Gil Y Cortes |
Address: | 9923 Menander Wood Court, Odessa, Florida 33556 |
Phone Number: | (813) 920-4036 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2009 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Health Services |
SIC Code: | 8099 |
NAICS Code: | 621999 |
Share This Business: |
Venus Dermatology & Internal Medicine P A was started in 2009 to provide professional Health Services under the SIC code 8099 and NAICS code 621999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Gil Y Cortes for inquiries that concern Venus Dermatology & Internal Medicine P A by calling the company number (813) 920-4036, as your correspondence is most welcome. Additionally, the physical location of the single location of Venus Dermatology & Internal Medicine P A can be found at the coordinates 28.105797,-82.57331 as well as the street address 9923 Menander Wood Court in Odessa, Florida 33556.
For its online presence, you may visit Venus Dermatology & Internal Medicine P A’s website at and engage with its social media outlets through on Twitter and on Facebook.